Please assess the completion status of the following clinical trial:

Trial Title: Patient Outcomes and Gingival Blood Flow Using Laser Doppler Flowmetry Following the Use of Episil on Free Gingival Graft Donor Sites

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patient of record at UTHealth School of Dentistry Houston Texas~* signed treatment plan for a FGG~* the ability to provide research informed consent~Exclusion Criteria:~* any allergies to any of the ingredients in episil including allergies to peanuts, soy or peppermint oil~* smokers~* pregnant or breast feeding women~* inability or unwillingness to provide informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- episil wound dressing (Type: EXPERIMENTAL): Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
- PeriAcryl90 wound dressing (Type: ACTIVE_COMPARATOR): PeriAcryl90 is a cyanoacrylate wound dressing.

Based on this trial design, predict the completion outcome and termination type (if applicable).